EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
We are looking for a new Chemistry curator to join the ChEBI team. Find out more about it here.
CHEBI:82960 - raltegravir
| Formula | C20H21FN6O5 |
| Net Charge | 0 |
| Average Mass | 444.423 |
| Monoisotopic Mass | 444.15575 |
| SMILES | Cc1nnc(C(=O)NC(C)(C)c2nc(C(=O)NCc3ccc(F)cc3)c(O)c(=O)n2C)o1 |
| InChI | InChI=1S/C20H21FN6O5/c1-10-25-26-17(32-10)16(30)24-20(2,3)19-23-13(14(28)18(31)27(19)4)15(29)22-9-11-5-7-12(21)8-6-11/h5-8,28H,9H2,1-4H3,(H,22,29)(H,24,30) |
| InChIKey | CZFFBEXEKNGXKS-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | HIV-1 integrase inhibitor An inhibitor of HIV-1 integrase, an enzyme required for the integration of the genetic material of the retrovirus into the DNA of the infected cells. antiviral agent A substance that destroys or inhibits replication of viruses. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. antiviral drug A substance used in the prophylaxis or therapy of virus diseases. anti-HIV agent An antiviral agent that destroys or inhibits the replication of the human immunodeficiency virus. |
| Applications: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. antiviral drug A substance used in the prophylaxis or therapy of virus diseases. antiinfective agent A substance used in the prophylaxis or therapy of infectious diseases. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| raltegravir (CHEBI:82960) has role anti-HIV agent (CHEBI:64946) |
| raltegravir (CHEBI:82960) has role antiinfective agent (CHEBI:35441) |
| raltegravir (CHEBI:82960) has role antineoplastic agent (CHEBI:35610) |
| raltegravir (CHEBI:82960) has role antiviral agent (CHEBI:22587) |
| raltegravir (CHEBI:82960) has role antiviral drug (CHEBI:36044) |
| raltegravir (CHEBI:82960) has role HIV-1 integrase inhibitor (CHEBI:67268) |
| raltegravir (CHEBI:82960) has role immunosuppressive agent (CHEBI:35705) |
| raltegravir (CHEBI:82960) is a 1,2,4-oxadiazole (CHEBI:46809) |
| raltegravir (CHEBI:82960) is a dicarboxylic acid amide (CHEBI:23690) |
| raltegravir (CHEBI:82960) is a hydroxypyrimidine (CHEBI:38340) |
| raltegravir (CHEBI:82960) is a monofluorobenzenes (CHEBI:83575) |
| raltegravir (CHEBI:82960) is a pyrimidone (CHEBI:38337) |
| raltegravir (CHEBI:82960) is a secondary carboxamide (CHEBI:140325) |
| IUPAC Name |
|---|
| N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(2-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}propan-2-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide |
| INNs | Source |
|---|---|
| raltegravir | WHO MedNet |
| raltegravir | WHO MedNet |
| raltégravir | WHO MedNet |
| raltegravirum | WHO MedNet |
| Synonyms | Source |
|---|---|
| L-000900612 | ChEMBL |
| L000900612 | ChEMBL |
| MK 0518 | ChemIDplus |
| MK-0518 | DrugCentral |
| MK0518 | DrugCentral |
| Registry Numbers | Sources |
|---|---|
| Reaxys:10696228 | Reaxys |
| CAS:518048-05-0 | ChemIDplus |
| Citations |
|---|